Cargando…
Medication adherence and glycemic control among newly diagnosed diabetes patients
BACKGROUND: Poor medication adherence can have negative consequences for the patients, the provider, the physician, and the sustainability of the healthcare system. To our knowledge, the association between medication adherence and glycemic control among newly diagnosed diabetes patients has not bee...
Autores principales: | Lin, Lee-Kai, Sun, Yan, Heng, Bee Hoon, Chew, Daniel Ek Kwang, Chong, Phui-Nah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574459/ https://www.ncbi.nlm.nih.gov/pubmed/28878942 http://dx.doi.org/10.1136/bmjdrc-2017-000429 |
Ejemplares similares
-
Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy
por: Wykoff, Charles C., et al.
Publicado: (2021) -
Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
por: Gordon, Jason, et al.
Publicado: (2018) -
Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes
por: McCoy, Rozalina G, et al.
Publicado: (2020) -
Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
por: Palladino, Raffaele, et al.
Publicado: (2020) -
Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes
por: Fang, Michael, et al.
Publicado: (2021)